Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Vitamins × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 2 Genitourinary 1 Gastrointestinal 1

Conditions

Carcinoma, Transitional Cell 1

Interventions

Docetaxel 373 pembrolizumab 289 Prednisone 263 enzalutamide 248 Gemcitabine 239 Magnetic Resonance Spectroscopy 238 Radiotherapy 237 Nivolumab 223 Abiraterone Acetate 191 Cisplatin 181 Radiosurgery 175 Leuprolide 173 Sunitinib 156 Carboplatin 144 Specimen Handling 135 Androgen Antagonists 133 bicalutamide 128 Goserelin 127 Paclitaxel 116 Ipilimumab 116 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 110 apalutamide 108 Cyclophosphamide 103 Everolimus 99 Sorafenib 96 Biopsy 96 cabozantinib 95 Bevacizumab 92 abiraterone 91 atezolizumab 88

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01490437 2014-09-25

PECULIAR

Asan Medical Center

Phase 2 Completed

Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡